Cargando…
Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review
Autophagy has been of novel interest since it was first demonstrated to have effect in Burkitt’s lymphoma. Since that time, the autophagy agents chloroquine and hydroxychloroquine have become the only FDA (Food and Drug Administration)-approved autophagy inhibitors. While not approved for cancer the...
Autores principales: | Mohsen, Samiha, Sobash, Philip T., Algwaiz, Ghada Fahad, Nasef, Noor, Al-Zeidaneen, Safaa Abed, Karim, Nagla Abdel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946974/ https://www.ncbi.nlm.nih.gov/pubmed/35323341 http://dx.doi.org/10.3390/curroncol29030141 |
Ejemplares similares
-
Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors
por: Sobash, Philip T., et al.
Publicado: (2022) -
Current Understanding of “Mixed Corticomedullary Adrenal Tumor” and an Insight into Genomic Profiling
por: Ullah, Asad, et al.
Publicado: (2022) -
A Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination With Carboplatin and Gemcitabine in Patients With Advanced Solid Tumors
por: Karim, Nagla Abdel, et al.
Publicado: (2022) -
Influenza Vaccination in Cancer Patients Undergoing Systemic Therapy
por: Shehata, Mahmoud A, et al.
Publicado: (2014) -
Exosomes as a Surrogate Marker for Autophagy in Peripheral Blood, Correlative Data from Phase I Study of Chloroquine in Combination with Carboplatin/Gemcitabine in Advanced Solid Tumors
por: Abdel-Karim, Nagla, et al.
Publicado: (2019)